Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003546493 | SCV004272855 | uncertain significance | not provided | 2024-01-13 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser829Trpfs*9) in the A2ML1 gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in A2ML1 cause disease. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with otitis media (PMID: 26121085). ClinVar contains an entry for this variant (Variation ID: 217306). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Department of Molecular and Human Genetics, |
RCV000201239 | SCV000255632 | pathogenic | Nonsyndromic otitis media | 2014-05-28 | no assertion criteria provided | research | |
OMIM | RCV000660876 | SCV000783113 | risk factor | Otitis media, susceptibility to | 2018-07-06 | no assertion criteria provided | literature only |